Dose-fractionated chemotherapy compared to standard chemotherapy, following surgery in women with newly diagnosed epithelial ovarian, fallopian tube or primary peritoneal cancer

http://isrctn.org/> ◽

10.1186/isrctn10356387 ◽

2012 ◽

Author(s):

Janet Cairns

Keyword(s):

Fallopian Tube ◽

Newly Diagnosed ◽

Standard Chemotherapy ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

ICON8: An international randomized trial comparing two dose-dense regimens, 3-weekly carboplatin plus weekly paclitaxel (CwT), and weekly carboplatin-paclitaxel (wCwT), to standard 3-weekly treatment in women with newly diagnosed ovarian, fallopian tube, and primary peritoneal cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps5611 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS5611-TPS5611 ◽

Author(s):

Jane Hook ◽

Sally Patricia Stenning ◽

James Brenton ◽

Stan B Kaye ◽

Iain A. McNeish ◽

...

Keyword(s):

Randomized Trial ◽

Fallopian Tube ◽

Weekly Paclitaxel ◽

Newly Diagnosed ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Weekly Treatment ◽

Download Full-text

A phase I study of continuous veliparib in combination with IV carboplatin/paclitaxel or IV/IP paclitaxel/cisplatin and bevacizumab in newly diagnosed patients with previously untreated epithelial ovarian, fallopian tube, or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.5507 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 5507-5507 ◽

Author(s):

Katherine M. Bell-McGuinn ◽

William E Brady ◽

Russell J. Schilder ◽

Paula M Fracasso ◽

Kathleen N. Moore ◽

...

Keyword(s):

Phase I ◽

Fallopian Tube ◽

Phase I Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Newly Diagnosed ◽

Oncology Group ◽

Oncology Group Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

A Randomized Phase II/III Trial of 3 Weekly Intraperitoneal versus Intravenous Carboplatin in Combination with Intravenous Weekly Dose-dense Paclitaxel for Newly Diagnosed Ovarian, Fallopian Tube and Primary Peritoneal Cancer

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyq182 ◽

2010 ◽

Vol 41 (2) ◽

pp. 278-282 ◽

Author(s):

K. Fujiwara ◽

E. Aotani ◽

T. Hamano ◽

S. Nagao ◽

H. Yoshikawa ◽

...

Keyword(s):

Fallopian Tube ◽

Phase Ii ◽

Weekly Dose ◽

Newly Diagnosed ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Randomized Phase Ii ◽

Download Full-text

Improved Optimal Cytoreduction Rates for Stages IIIC and IV Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer: A Change in Surgical Approach

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70606-4 ◽

2006 ◽

Vol 2006 ◽

pp. 466-467

Author(s):

G. Rodriguez

Keyword(s):

Fallopian Tube ◽

Surgical Approach ◽

Optimal Cytoreduction ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

PREDICTING OUTCOME IN EPITHELIAL OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CANCER ACCORDING TO HISTOLOGICAL TUMOUR RESPONSE TO NEO-ADJUVANT CHEMOTHERAPY, AT THE TIME OF INTERVAL DEBULKING.

10.26226/morressier.5770e29cd462b80290b4c049 ◽

2016 ◽

Author(s):

Sinead Barry

Keyword(s):

Adjuvant Chemotherapy ◽

Fallopian Tube ◽

Tumour Response ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Predicting Outcome ◽

Neo Adjuvant Chemotherapy

Download Full-text

Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Case Medical Research ◽

10.31525/ct1-nct03907527 ◽

2019 ◽

Author(s):

Keyword(s):

T Cells ◽

Fallopian Tube ◽

Immune Cells ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Car T Cells ◽

Platinum Resistant ◽

Download Full-text

Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Yearbook of Oncology ◽

10.1016/j.yonc.2011.07.017 ◽

2011 ◽

Vol 2011 ◽

pp. 78-79

Author(s):

J.T. Thigpen

Keyword(s):

Ovarian Cancer ◽

Fallopian Tube ◽

Clinical Activity ◽

Fallopian Tube Cancer ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Platinum Resistant

Download Full-text

Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian, fallopian tube and/or primary peritoneal cancer

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd012567 ◽

2017 ◽

Author(s):

Jacob P Hoogendam ◽

Joline F Roze ◽

Fleur T van de Wetering ◽

René Spijker ◽

Leen Verleye ◽

...

Keyword(s):

Magnetic Resonance Imaging ◽

Positron Emission Tomography ◽

Magnetic Resonance ◽

Fallopian Tube ◽

Emission Tomography ◽

Resonance Imaging ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Positron Emission ◽

Magnetic Resonance Imaging Mri

Download Full-text

CYTOREDUCTIVE SURGERY (CRS) AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) IN PATIENTS WITH ADVANCED OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER: OUR EXPERIENCE IN 108 PATIENTS

10.26226/morressier.5d2ee8eb1e09a6f49485abf9 ◽

2019 ◽

Author(s):

Mihai Emil Capilna ◽

MIHAI GHEORGHE ◽

Szilard Leo Kiss ◽

Alexandra Lavinia Cozlea

Keyword(s):

Fallopian Tube ◽

Intraperitoneal Chemotherapy ◽

Cytoreductive Surgery ◽

Hyperthermic Intraperitoneal Chemotherapy ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

The Lancet Oncology ◽

10.1016/s1470-2045(13)70363-2 ◽

2013 ◽

Vol 14 (10) ◽

pp. 1020-1026 ◽

Author(s):

Noriyuki Katsumata ◽

Makoto Yasuda ◽

Seiji Isonishi ◽

Fumiaki Takahashi ◽

Hirofumi Michimae ◽

...

Keyword(s):

Fallopian Tube ◽

Long Term Results ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Open Label Trial ◽

Randomised Controlled

Download Full-text